Boulahrouz R, Stanescu C, Charasse C, Ang K S, Le Cacheux P, Leonetti F, Rioux N, Ramee M P, Simon P
Service de néphrologie, centre hospitalier Yves Le Foll, Saint-Brieuc.
Arch Mal Coeur Vaiss. 2004 Jul-Aug;97(7-8):782-5.
Worse prognosis of IgA nephropathy (IgAN) is associated to hypertension, high proteinuria, glomerular and vascular sclerosis. A family story of hypertension (FHT) in relatives could be a strong predictor of the occurrence of hypertension (HT) in children. Renal vascular lesions (RVL) are often observed in normotensive patients with IgAN. In order to evaluate a possible association between FHT and LVR in patients with IgAN, we investigated two groups of 73 IgAN patients, sex (56 males and 17 females) and age matched, according to the presence or not of FHT. FHT was diagnosed if relatives and/or at least one child under 60 years of age had treatment for HT or systolic and diastolic BP over 140/90 mmHg at the time of the survey. Patients entering into the study were followed during an average period of 5 to 8 years. At the end of the study, all patients were explored for HT and renal function. Creatinine clearance (CrCl) was evaluated by Cockcroft and Gault formula and renal failure was defined as CrCl<60mL/min. The results were as follow: at the time of renal biopsy, RVL were observed in 73% of males with FHT vs 16% of males without FHT (p<0.0001) and 70.6% of females with FHT vs 29.4% of females without FHT (p<0.001); at the end of the study period, HT was significantly associated to FHT in 89.6% of patients group with FHT vs 22.6% of HT patients in the group without FHT (p<.0001). Renal failure was present in 45.2% of patients with FHT vs 4.1% of patients without FHT (p<0.0001). These data suggest: VRL could be dependent of genetic factors; FHT should be an early predictor of VRL in patients with IgAN; FHT might be a risk factor for renal failure in patients with this renal disease.
IgA肾病(IgAN)预后较差与高血压、高蛋白尿、肾小球和血管硬化有关。亲属中有高血压家族史(FHT)可能是儿童发生高血压(HT)的有力预测指标。在血压正常的IgAN患者中常观察到肾血管病变(RVL)。为了评估IgAN患者中FHT与LVR之间可能存在的关联,我们根据是否存在FHT对两组各73例IgAN患者进行了调查,这两组患者在性别(56例男性和17例女性)和年龄上相匹配。如果亲属和/或至少一名60岁以下儿童接受过高血压治疗,或在调查时收缩压和舒张压超过140/90 mmHg,则诊断为FHT。参与研究的患者平均随访5至8年。研究结束时,对所有患者进行了高血压和肾功能检查。肌酐清除率(CrCl)采用Cockcroft和Gault公式评估,肾衰竭定义为CrCl<60mL/分钟。结果如下:在肾活检时,有FHT的男性中73%观察到RVL,无FHT的男性中为16%(p<0.0001);有FHT的女性中70.6%观察到RVL,无FHT的女性中为29.4%(p<0.001);在研究期结束时,有FHT的患者组中89.6%的患者高血压与FHT显著相关,无FHT组中高血压患者为22.6%(p<.0001)。有FHT的患者中45.2%出现肾衰竭,无FHT的患者中为4.1%(p<0.0001)。这些数据表明:VRL可能取决于遗传因素;FHT应该是IgAN患者VRL的早期预测指标;FHT可能是这种肾脏疾病患者肾衰竭的危险因素。